These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35315990)

  • 1. The remission phase in adolescents and young adults with newly diagnosed type 1 diabetes mellitus: prevalence, predicting factors and glycemic control during follow-up.
    Yazidi M; Mahjoubi S; Oueslati I; Chaker F; Chihaoui M
    Arch Endocrinol Metab; 2022 Apr; 66(2):222-228. PubMed ID: 35315990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete remission in children and adolescents with type 1 diabetes mellitus-prevalence and factors.
    Podolakova K; Barak L; Jancova E; Tarnokova S; Podracka L; Dobiasova Z; Skopkova M; Gasperikova D; Stanik J
    Sci Rep; 2023 Apr; 13(1):6790. PubMed ID: 37100887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial clinical remission in type 1 diabetes: a comparison of the accuracy of total daily dose of insulin of <0.3 units/kg/day to the gold standard insulin-dose adjusted hemoglobin A1c of ≤9 for the detection of partial clinical remission.
    Lundberg RL; Marino KR; Jasrotia A; Maranda LS; Barton BA; Alonso LC; Nwosu BU
    J Pediatr Endocrinol Metab; 2017 Aug; 30(8):823-830. PubMed ID: 28753540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of remission and its duration on development of early microvascular complications in young adults with type 1 diabetes.
    Niedzwiecki P; Pilacinski S; Uruska A; Adamska A; Naskret D; Zozulinska-Ziolkiewicz D
    J Diabetes Complications; 2015; 29(8):1105-11. PubMed ID: 26427560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketoacidosis at onset of type 1 diabetes is a predictor of long-term glycemic control.
    Shalitin S; Fisher S; Yackbovitch-Gavan M; de Vries L; Lazar L; Lebenthal Y; Phillip M
    Pediatr Diabetes; 2018 Mar; 19(2):320-328. PubMed ID: 28568379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial remission in children and adolescents with type 1 diabetes: an analysis based on the insulin dose-adjusted hemoglobin A1c.
    Cimbek EA; Bozkır A; Usta D; Beyhun NE; Ökten A; Karagüzel G
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1311-1317. PubMed ID: 34271601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in insulin sensitivity in the partial remission phase of childhood type 1 diabetes; a longitudinal cohort study.
    Mørk FCB; Madsen JOB; Jensen AK; Hall GV; Pilgaard KA; Pociot F; Johannesen J
    Diabet Med; 2022 Feb; 39(2):e14702. PubMed ID: 34564895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study.
    Cengiz E; Cheng P; Ruedy KJ; Kollman C; Tamborlane WV; Klingensmith GJ; Gal RL; Silverstein J; Lee J; Redondo MJ; Beck RW;
    Pediatr Diabetes; 2017 Nov; 18(7):566-573. PubMed ID: 27758023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents.
    Böber E; Dündar B; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2001 Apr; 14(4):435-41. PubMed ID: 11327378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual and diabetes presentation characteristics associated with partial remission status in children and adults evaluated up to 12 months following diagnosis of type 1 diabetes: An ADDRESS-2 (After Diagnosis Diabetes Research Support System-2) study analysis.
    Humphreys A; Bravis V; Kaur A; Walkey HC; Godsland IF; Misra S; Johnston DG; Oliver NS
    Diabetes Res Clin Pract; 2019 Sep; 155():107789. PubMed ID: 31326456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers influencing the presence of partial clinical remission in patients with newly diagnosed type 1 diabetes.
    Pyziak A; Zmyslowska A; Bobeff K; Malachowska B; Fendler W; Wyka K; Baranowska-Jazwiecka A; Szymanska M; Szadkowska A; Mlynarski W
    J Pediatr Endocrinol Metab; 2017 Oct; 30(11):1147-1153. PubMed ID: 29016353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.
    Pinckney A; Rigby MR; Keyes-Elstein L; Soppe CL; Nepom GT; Ehlers MR
    Clin Ther; 2016 Jun; 38(6):1327-1339. PubMed ID: 27209482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal glycemic control in adolescents and young adults with type 1 diabetes from 2011 to 2020 across Australia and New Zealand: Data from the Australasian Diabetes Data Network registry.
    James S; Perry L; Lowe J; Harris M; Craig ME;
    Pediatr Diabetes; 2022 Sep; 23(6):736-741. PubMed ID: 35561056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial remission in type 1 diabetes and associated factors: Analysis based on the insulin dose-adjusted hemoglobin A1c in children and adolescents from a regional diabetes center, Auckland, New Zealand.
    Chiavaroli V; Derraik JGB; Jalaludin MY; Albert BB; Ramkumar S; Cutfield WS; Hofman PL; Jefferies CA
    Pediatr Diabetes; 2019 Nov; 20(7):892-900. PubMed ID: 31237756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An online tool using clinical factors to estimate the probability of partial clinical remission of adult-onset Type 1 diabetes.
    Januszewski AS; Grzelka-Wozniak A; Flotynska J; Jenkins AJ; Zozulinska-Ziolkiewicz DA; Uruska AA
    J Diabetes Complications; 2024 Sep; 38(9):108828. PubMed ID: 39084177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences over time for glycemic control, pump use and insulin dose in patients aged 10-40 years with type 1 diabetes: a diabetes registry study.
    Boettcher C; Tittel SR; Meissner T; Gohlke B; Stachow R; Dost A; Wunderlich S; Lowak I; Lanzinger S
    BMJ Open Diabetes Res Care; 2021 Dec; 9(2):. PubMed ID: 34969693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predicting poor glycemic control in the first two years of childhood onset type 1 diabetes in a cohort from East London, UK: Analyses using mixed effects fractional polynomial models.
    Mazarello Paes V; Barrett JK; Dunger DB; Gevers EF; Taylor-Robinson DC; Viner RM; Stephenson TJ
    Pediatr Diabetes; 2020 Mar; 21(2):288-299. PubMed ID: 31782879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes.
    Marino KR; Lundberg RL; Jasrotia A; Maranda LS; Thompson MJ; Barton BA; Alonso LC; Nwosu BU
    PLoS One; 2017; 12(5):e0176860. PubMed ID: 28459844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.